Background. Historical recordssuggestdyskinesiawas observedin severelyiNinstitutiona lised patients with schizophrenia in the pre-neuroleptic era. More recent work has not found dyskinesia in never-medicated younger and middle aged patients. The present study comple mentsthis recentwork and avoidsthe confoundersof severityof illnessand institutionalism by examiningelderlypatientsin a wide varietyof communitysettings. Method. Movementdisorderswere examinedin308 elderlyindividuals in Madras,India,using theAbnormal Invokintary Movements Scale,the Simpson and Angus Parkinsonism Scale and the BarnesAkathisiaScale. Patient&mentalstatewas assessedby the Positiveand Negative SyndromeScale
movements was found in never-medicated middle aged schizophrenic patients (mean age 42 years, ill on average for 12 years). In contrast, in a study from England abnormal movements were found in 53% of never-medicated elderly schizophrenic patients (mean age 67 years) (Owens et a!, 1982). There are two principal differences between the studies that have and have not found movement disorders in never-medicated patients. Firstly, the former probably examined severely ill patients and are thus not representative of the whole range of schizophrenic patients. Secondly, those patients in the main were institutionalised; it has been suggested institutionalised patients have higher prevalence rates of â€˜¿ spontaneous' dyskinesia (Casey & Hansen, 1984) . However, disentangling institu tionalism from severity of illness is difficult.
The present study complements the recent studies of young and middle aged patients by examining elderly schizophrenic patients. It avoids the two possible confounders of severity of illness and institutionalism by examining patients drawn from a wide range of community settings. It also compares the prevalence of movement disorders in never-medicated with medicated patients, first degree blood relatives of schizophrenic patients and normal subjects.
Background schizophrenic patients; day attenders and residents at facility (4) and who were not mentally ill; staff at (1), (2) and (4); and community mental health workers attached to (5). Again the minimum age for inclusion was 50 years. 
Assessment

Medication
The patients' lifetime exposure to antipsychotic medication was determined through discussion with patients and relatives, and examination of case records and prescription sheets. Taking antipsycho tic medication is an important, and often expensive event in the lives of schizophrenic patients and their relatives in Madras. We are satisfied that accurate medication histories were obtained, especially in the case of those who had never had such medication.
The latter were drawn mainly from the slums and from the rural outreach centre (see above).
Other information
The following additional information about pa tients and control subjects was recorded: age, gender, marital status; and for patients, age of onset of illness, and length of illness.
Results
In all, 308 individuals were assessed: 21 never medicated patients, 83 medicated patients, 103 relatives and 101 normal subjects. 
Patients
Patients were recruited from a variety of settings:
(1) out-patients and day patients attending the SCARF centre in Madras city; (2) in-patients in a short stay rehabilitation unit, run by SCARF on the outskirts of Madras; (3) attenders at a day centre run by families of schizophrenic patients; (4) residents of three homes for the elderly, one in the slums of Madras, two in the suburbs; (5) out patients at a rural outreach facility, run by SCARF 40 km south of Madras; (6) out-patients attending psychiatrists in private practice. The minimum age for inclusion was 50 years. All patients fulfilled DSMâ€"IVcriteria for schizophrenia (American Psychiatric Association, 1994). The diagnosis was made through mental state examination (see below) and history obtained from patients, relatives and case records where available.
Control subjects
There are two types of control subjects: firstly, first degree blood relatives of schizophrenic patients; these were mainly fathers and mothers of younger schizophrenic patients attending facilities (1), (3) and (5) (see above). Secondly, normal subjects were recruited: these were husbands and wives of 
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McCREADIEET AL controls (22% and 1% respectively had moderate or severe dyskinesia: x2 = 38.0, d.f. = 1, P<0.000l). There were no significant differences in the severity of orofacial and distal dyskinesia between never medicated and medicated patients, but orofacial dyskinesia was more severe in patients than in controls (analysis of variance: F= 10.56, P<0.05).
As medicated patients were significantly younger than the other three groups a further analysis was carried out only in those aged over 60 years. The prevalence of dyskinesia in normal subjects (n = 57), relatives (n = 53), medicated patients (n = 23) and never-medicated patients (n = 14) was respectively 21%, 28%, 43% and 43% (patients v. normals:
x2=3.8, d.f.@l, P=0.05).
Patients with and without dyskinesia were compared on the basisof gender,age,lengthof illness, total length of time on antipsychotic medication and PANSS ratings; and control sub jects with and without dyskinesia on gender and age (Table 3 ). The only significant differences were that normal subjects and relatives with dyskinesia were older than those without dyskinesia (normals: z=4.3, P<0.000l; relatives: t=3.8, P==0.0002); that more medicated patients with early onset schizophrenia (ill more than 10 years) had dyskine sia compared with late onset patients (ill less than five years) (f = 4.1, d.f. = 1, P = 0.04); and that medicatedpatients withdyskinesia had more severe negative symptoms than those without dyskinesia (1= 2.7, P = 0.009) (a similar differencein never medicated patients was not statistically significant).
Four of the 103 relatives were in fact relatives of patients in the study. One relative but not the corresponding patient had dyskinesia; one patient but not the relative had dyskinesia; and two patients and their relatives had no dyskinesia.
Parkinsonism, defined as a score ofmore than 0.3 on the Simpson & Angus scale, was present in 6% of normal subjects, 11% relatives, 24% never medicated patients and 36% medicated patients (@2 34.1, d .f. = 3, P<0.000l). Within the never medicated group the prevalence of dyskinesia in those with Parkinsonism was similar to that in those without Parkinsonism. Of those in the never treated group with Parkinsonism (n =5) all had rigidity but only one had a tremor.Akathisia, defined as a score of at least 2 on the global scale, was found in 9% of normal subjects, 5% relatives, 21% never-medicated patients, and 23% medicated patients (f = 17.2, d.f. =3, P = 0.0006). Only three patients, all on medication, had objective evidence of akathisia.
Discussion
Western readers may be surprised that a minimum age of 50 years was chosen to define the â€˜¿ elderly'.
Table3
Patients andcontrol subjects withandwithout dyskinesia , 1990) ; the same may well be true in India.
General impressions
We comment below on the significance of the AIMS results. However, quantitative scores can not describe adequately the movement disorders shown by the patients, especially those who had never had antipsychotic medication. Repeatedly, when the rater who assessed movement disorders (RGMcC, a psychiatrist who has personally carried out more than 1500 ratings using the AIMS scale) was told afterwards that a patient had never had medication, he said, â€oe¿ It was just like classic TDâ€•.By this he meant, for example, chewing movements, pursing and smacking of the lips, and writhing move ments and protrusion of the tongue. A follow-up is planned and we hope then to make video-recordings.
Interpretation of findings
The prevalence of dyskinesia in control subjects, 15%, is similar to that found in other studies of normal elderly subjects: 10% (Varga et a!, 1982) and 18% (Bourgeois et a!, 1980) . There was no difference in the prevalence of dyskinesia in normal subjects and first degree blood relatives, mainly fathers and mothers of younger schizophrenic patients. Although presumably the relatives share many of the genes of their ill offspring, our findings suggest that the illness must become manifest before the prevalence of dyskinesia rises.
The prevalence and severity of dyskinesia was significantly greater in patients than in control subjects and dyskinesia was as common and as severe in never-medicated as in medicated patients. The medicated were younger than the never medicated patients, but when only those aged over 60 years were considered, the prevalence of dys kinesia remained the same in both groups (43%) and significantly greater than in the control groups. We believe therefore that it is the illness per se and not antipsychotic medication that is associated with dyskinesia in elderly schizophrenic patients.
Two further factors within the patient groups were associated with dyskinesia. Firstly the type, or length of illness: those with early onset schizo phrenia, ill for more than 10 years were more likely to show dyskinesia than those with late onset schizo phrenia, ill forless than 5 years. Secondly, dyskinesia was associated with negative symptoms, an associa tion statistically significant in medicated patients. This association has been shown before in most but not all studies (for a review, see Waddington, 1995).
Twenty-four per cent ofnever-medicated patients had Parkinsonism. This prevalence, lying between that of control subjects and medicated patients, is very similar to that in a previous study of newly diagnosed and never-medicated patients (21%; Caligiuri et a!, 1993); that study found, as did ours, that rigidity was common, but tremor rare. There fore muscle rigidity may also be a feature of the schizophrenic illness.
Akathisia was as common in never-medicated as in medicated patients and more common in patients than in control subjects. Akathisia as assessed by the Barnes scale has two components: an inner sense of restlessness and objective evidence of motor abnormalities. Only three patients, all receiving medication, had objective motor abnorm alities. Our findings suggest an inner sense of restlessness may be a symptom of illness in some patients. However, our interpreter found it hard to convey to the patient the difference between restlessness and tension; she had a problem finding the appropriate equivalents for these terms in the Tamil language. It is possible therefore that some people may have been describing tension as part of anxiety rather than true akathisia.
Tbeoretlcal Issues
How might dyskinesia be produced in elderly schizophrenic patients? The simplest explanation is that it is a non-specific effect of brain ageing or atrophy on the schizophrenic process. A more elaborate explanation (Davis et a!, 1991; Fenton et a!, 1994) invokes the current dopanune hypothesis which suggests that â€˜¿ hypofrontality', low dopamine activity in the prefrontal cortex, may be associated with or indeed triggerincreased dopamine activity in the striatal circuits of the mesolimbic system. It is suggested that the hypofrontal state is associated with negative symptoms and inferior cognitive performance and the hyperdopaminergic mesolim bic state is associated with positive psychotic symptoms and spontaneous dyskinetic movements. But why should dyskinesia be found in elderly but not in younger or middle aged patients? A possible explanation is that hypofrontality, which triggersoff increased mesolimbic activity, only develops after many years of illness.
